or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    IOVA F Iovance Biotherapeutics, Inc. 1.52
    CLLS F Cellectis S.A. 0.00
    NXTC F NextCure, Inc. -3.10
    SLRX F Salarius Pharmaceuticals, Inc. 0.00
    ORIC F Oric Pharmaceuticals, Inc. 1.54
    CRIS F Curis, Inc. 0.00
    IMRX F Immuneering Corporation 3.70
    ANIX F Anixa Biosciences, Inc. 15.52
    ESLA F Estrella Immunopharma, Inc. 1.12
    HALO F Halozyme Therapeutics, Inc. 5.74
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Biotechnology Cancer Medicine Biopharmaceutical Clinical Medicine Acute Myeloid Leukemia Cancer Treatment Immune System Immunology Monoclonal Antibodies Antibodies Antibody Drug Conjugate Blood Cancers CD19 Cancer Immunotherapy Enzymes Immunotherapy Leukemia Monoclonal Antibody Ovarian Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 3.44
    SBIO C ALPS Medical Breakthroughs ETF 3.27
    CANC D Tema Oncology ETF 2.81
    CNCR F Loncar Cancer Immunotherapy ETF 2.8
    CSMD A Congress SMid Growth ETF 2.45
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CANC to CNCR Compare CANC to CSMD Compare FBT to CSMD

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 20 HALO Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
        Nov 19 HALO 3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
        Nov 19 HALO HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
        Nov 19 HALO Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?
        Nov 19 HALO Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
        Nov 19 NXTC Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
        Nov 18 ANIX Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
        Nov 18 HALO Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
        Nov 17 HALO Halozyme plans to finance $2.1B takeover of Evotech in cash: report
        Nov 17 HALO Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
        Nov 15 HALO Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer
        Nov 15 HALO Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Biotechnology Cancer Medicine Biopharmaceutical Clinical Medicine Acute Myeloid Leukemia Cancer Treatment Immune System Immunology Monoclonal Antibodies Antibodies Antibody Drug Conjugate Blood Cancers CD19 Cancer Immunotherapy Enzymes Immunotherapy Leukemia Monoclonal Antibody Ovarian Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags